<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><!-- generator="bbPress" --><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">

<channel>
<title>pharmaphorum forums » Recent Posts</title>
<link>http://www.pharmaphorum.com/forums/</link>
<description>Bringing Healthcare Together</description>
<language>en</language>
<pubDate>Fri, 25 May 2012 15:33:37 +0000</pubDate>

<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/pharmaphorum-forums" /><feedburner:info uri="pharmaphorum-forums" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item>
<title>News on "Mylan settles patent suit over Sunovion's lung drug"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/yTvuLrr07lk/mylan-settles-patent-suit-over-sunovions-lung-drug</link>
<pubDate>Fri, 25 May 2012 15:59:00 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4925@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Settlement relates to infringements by Mylan's COPD drug Brovana (arformoterol tartrate)...&lt;/p&gt;
&lt;p&gt;More on the story at Reuters:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://uk.reuters.com/article/2012/05/24/us-mylan-idUKBRE84N1OP20120524" target="_blank"&gt;http://uk.reuters.co...dUKBRE84N1OP20120524&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/yTvuLrr07lk" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/mylan-settles-patent-suit-over-sunovions-lung-drug#post-4925</feedburner:origLink></item>
<item>
<title>News on "Japan’s Takeda Strikes Brazil Drug Deal"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/oORnoKgYpmU/japan%e2%80%99s-takeda-strikes-brazil-drug-deal</link>
<pubDate>Fri, 25 May 2012 15:54:56 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4924@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Acquisition priced at US$246 million...&lt;/p&gt;
&lt;p&gt;More on the story at a Wall Street Journal blog:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://blogs.wsj.com/deals/2012/05/25/japans-takeda-strikes-brazil-drug-deal/" target="_blank"&gt;http://blogs.wsj.com...es-brazil-drug-deal/&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/oORnoKgYpmU" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/japan%e2%80%99s-takeda-strikes-brazil-drug-deal#post-4924</feedburner:origLink></item>
<item>
<title>News on "Greece Close to Health Crisis As Drugs Run Low"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/nQjQg3QGHPs/greece-close-to-health-crisis-as-drugs-run-low</link>
<pubDate>Fri, 25 May 2012 09:52:24 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4923@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Warning of 'chaos' if European funding is not released...&lt;/p&gt;
&lt;p&gt;More on the story at PharmaLive:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://pharmalive.com/News/index.cfm?articleid=841451" target="_blank"&gt;http://pharmalive.co...cfm?articleid=841451&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/nQjQg3QGHPs" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/greece-close-to-health-crisis-as-drugs-run-low#post-4923</feedburner:origLink></item>
<item>
<title>News on "ESHLSG publishes transparency principles for clinical trials"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/udhuZJJp3oo/eshlsg-publishes-transparency-principles-for-clinical-trials</link>
<pubDate>Fri, 25 May 2012 09:50:05 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4922@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Publication of document 'Clinical trial transparency principles and facts'...&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.pharmatimes.com/Article/12-05-24/ESHLSG_publishes_transparency_principles_for_clinical_trials.aspx" target="_blank"&gt;http://www.pharmatim...clinical_trials.aspx&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/udhuZJJp3oo" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/eshlsg-publishes-transparency-principles-for-clinical-trials#post-4922</feedburner:origLink></item>
<item>
<title>News on "Novartis net profits dips by 18% to US $2,327 million in Q1"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/mYjZkxp1jfs/novartis-net-profits-dips-by-18-to-us-2327-million-in-q1</link>
<pubDate>Fri, 25 May 2012 09:41:55 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4921@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Almost half a billion US dollars taken off Novartis's multi-billion dollar profit line...&lt;/p&gt;
&lt;p&gt;More on the story at Pharmabiz:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://pharmabiz.com/NewsDetails.aspx?aid=69194&amp;amp;sid=2" target="_blank"&gt;http://pharmabiz.com...?aid=69194&amp;amp;sid=2&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/mYjZkxp1jfs" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/novartis-net-profits-dips-by-18-to-us-2327-million-in-q1#post-4921</feedburner:origLink></item>
<item>
<title>News on "PPD taps Pfizer executive Simmons for chairman, CEO roles"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/WzbXPCt73DY/ppd-taps-pfizer-executive-simmons-for-chairman-ceo-roles</link>
<pubDate>Thu, 24 May 2012 15:54:01 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4919@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;New chairman and chief executive at contract research firm Pharmaceutical Product Development (PPD) is ex-Pfizer executive...&lt;/p&gt;
&lt;p&gt;More on the story at Pharma Times:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.pharmatimes.com/Article/12-05-24/PPD_taps_Pfizer_executive_Simmons_for_chairman_CEO_roles.aspx" target="_blank"&gt;http://www.pharmatim...irman_CEO_roles.aspx&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/WzbXPCt73DY" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/ppd-taps-pfizer-executive-simmons-for-chairman-ceo-roles#post-4919</feedburner:origLink></item>
<item>
<title>News on "China has more pharma sales reps than US for first time"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/uvmeViKKDJ0/china-has-more-pharma-sales-reps-than-us-for-first-time</link>
<pubDate>Thu, 24 May 2012 09:21:11 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4918@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Chinese pharma sales force numbers some 80,000...&lt;/p&gt;
&lt;p&gt;More on the story at PMLiVE:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.pmlive.com/pharma_news/china_overtakes_us_number_pharma_sales_reps_404785" target="_blank"&gt;http://www.pmlive.co...ma_sales_reps_404785&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/uvmeViKKDJ0" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/china-has-more-pharma-sales-reps-than-us-for-first-time#post-4918</feedburner:origLink></item>
<item>
<title>News on "Vital FDA bill plods though Senate"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/XTwROvxsI74/vital-fda-bill-plods-though-senate</link>
<pubDate>Thu, 24 May 2012 09:16:39 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4917@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Legislation in the US to ensure the Food and Drug Administration can continue with lesser approval times...&lt;/p&gt;
&lt;p&gt;More on the story at Nature news blog:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://blogs.nature.com/news/2012/05/vital-fda-bill-plods-though-senate.html" target="_blank"&gt;http://blogs.nature....s-though-senate.html&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/XTwROvxsI74" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/vital-fda-bill-plods-though-senate#post-4917</feedburner:origLink></item>
<item>
<title>News on "New CEO takes the helm at biotech giant Amgen"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/ccDSkZJY4GU/new-ceo-takes-the-helm-at-biotech-giant-amgen</link>
<pubDate>Thu, 24 May 2012 09:13:33 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4916@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Bob Bradway takes the baton from retiring chief executive Kevin Sharer...&lt;/p&gt;
&lt;p&gt;More on the story at Bloomberg Businessweek:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.businessweek.com/ap/2012-05/D9UUMA500.htm" target="_blank"&gt;http://www.businessw...012-05/D9UUMA500.htm&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/ccDSkZJY4GU" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/new-ceo-takes-the-helm-at-biotech-giant-amgen#post-4916</feedburner:origLink></item>
<item>
<title>News on "U.S. advisers reject J&amp;J/Bayer's Xarelto for acute coronary patients"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/5adg6FK0paI/us-advisers-reject-jjbayers-xarelto-for-acute-coronary-patients</link>
<pubDate>Thu, 24 May 2012 09:09:55 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4915@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Block on expanded use for Xarelto (rivaroxaban) in coronary patients...&lt;/p&gt;
&lt;p&gt;More on the story at Reuters:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://uk.reuters.com/article/2012/05/24/us-fda-jj-idUKBRE84M1EH20120524" target="_blank"&gt;http://uk.reuters.co...dUKBRE84M1EH20120524&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/5adg6FK0paI" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/us-advisers-reject-jjbayers-xarelto-for-acute-coronary-patients#post-4915</feedburner:origLink></item>
<item>
<title>News on "Novo Nordisk gets US FDA nod for expanded use of Levemir in children with type 1 diabetes"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/rV9lCKybHYE/novo-nordisk-gets-us-fda-nod-for-expanded-use-of-levemir-in-children-with-type-1-diabetes</link>
<pubDate>Wed, 23 May 2012 15:19:33 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4914@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Children between the ages of two and five years with type 1 diabetes will be able to benefit from Levemir (insulin detemir [rDNA origin] injection)...&lt;/p&gt;
&lt;p&gt;More on the story at PharmaBiz:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://pharmabiz.com/NewsDetails.aspx?aid=69162&amp;amp;sid=2" target="_blank"&gt;http://pharmabiz.com...?aid=69162&amp;amp;sid=2&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/rV9lCKybHYE" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/novo-nordisk-gets-us-fda-nod-for-expanded-use-of-levemir-in-children-with-type-1-diabetes#post-4914</feedburner:origLink></item>
<item>
<title>News on "French biotech sector struggling"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/gCmSeUHAJlk/french-biotech-sector-struggling</link>
<pubDate>Wed, 23 May 2012 15:12:54 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4913@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Number of biotechs established in France has taken a plunge...&lt;/p&gt;
&lt;p&gt;More on the story at the Nature news blog:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://blogs.nature.com/news/2012/05/french-biotech-sector-struggling.html" target="_blank"&gt;http://blogs.nature....ctor-struggling.html&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/gCmSeUHAJlk" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/french-biotech-sector-struggling#post-4913</feedburner:origLink></item>
<item>
<title>News on "GSK says amends Human Genome tender offer conditions"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/FrATJbnug9o/gsk-says-amends-human-genome-tender-offer-conditions</link>
<pubDate>Wed, 23 May 2012 15:10:09 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4912@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;GlaxoSmithKline responds to poison pill that has been designed by Human Genome Sciences to fend off the hostile bid...&lt;/p&gt;
&lt;p&gt;More on the story at Reuters:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://uk.reuters.com/article/2012/05/23/uk-gsk-hg-idUKBRE84M0QF20120523" target="_blank"&gt;http://uk.reuters.co...dUKBRE84M0QF20120523&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/FrATJbnug9o" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/gsk-says-amends-human-genome-tender-offer-conditions#post-4912</feedburner:origLink></item>
<item>
<title>News on "The End Of DTC TV Ads? Sanofi Says Maybe"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/gZBUSpHGDj0/the-end-of-dtc-tv-ads-sanofi-says-maybe</link>
<pubDate>Wed, 23 May 2012 09:42:40 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4911@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Will direct-to-consumer advertising in the US become too expensive as a result of red tape?&lt;/p&gt;
&lt;p&gt;More on the question at Pharmalot:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.pharmalot.com/2012/05/the-end-of-dtc-tv-ads-sanofi-says-maybe/" target="_blank"&gt;http://www.pharmalot...s-sanofi-says-maybe/&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/gZBUSpHGDj0" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/the-end-of-dtc-tv-ads-sanofi-says-maybe#post-4911</feedburner:origLink></item>
<item>
<title>News on "US study warns drugmakers over cost/effectiveness data"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/GGdVuKPAu6g/us-study-warns-drugmakers-over-costeffectiveness-data</link>
<pubDate>Wed, 23 May 2012 09:39:49 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4910@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Survey suggests pharma needs to make a more impressive economic case for products...&lt;/p&gt;
&lt;p&gt;More on the story at Pharma Times:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.pharmatimes.com/Article/12-05-21/US_study_warns_drugmakers_over_cost_effectiveness_data.aspx" target="_blank"&gt;http://www.pharmatim...ectiveness_data.aspx&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/GGdVuKPAu6g" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/us-study-warns-drugmakers-over-costeffectiveness-data#post-4910</feedburner:origLink></item>
<item>
<title>News on "Merck CEO: Generics, economy to make 2012-13 tough"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/wBpHZJmvsDQ/merck-ceo-generics-economy-to-make-2012-13-tough</link>
<pubDate>Wed, 23 May 2012 09:30:57 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4909@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Merck's chief executive Kenneth Frazier gave the warning in a presentation to shareholders...&lt;/p&gt;
&lt;p&gt;More on the story at Bloomberg Business Week:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.businessweek.com/ap/2012-05/D9UTRV9G0.htm" target="_blank"&gt;http://www.businessw...012-05/D9UTRV9G0.htm&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/wBpHZJmvsDQ" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/merck-ceo-generics-economy-to-make-2012-13-tough#post-4909</feedburner:origLink></item>
<item>
<title>News on "Bayer, Onyx cancer drug fails in late-stage study"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/E66tu5Z4l4M/bayer-onyx-cancer-drug-fails-in-late-stage-study</link>
<pubDate>Wed, 23 May 2012 09:24:25 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4908@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Nexavar (sorafenib) failed to reach goals as a second-line therapy in advanced relapsed or refractory non-squamous non-small cell lung cancer in a phase III trial...&lt;/p&gt;
&lt;p&gt;More on the story at Bloomberg Businessweek:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.businessweek.com/ap/2012-05/D9UTNAIO1.htm" target="_blank"&gt;http://www.businessw...012-05/D9UTNAIO1.htm&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/E66tu5Z4l4M" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/bayer-onyx-cancer-drug-fails-in-late-stage-study#post-4908</feedburner:origLink></item>
<item>
<title>vadodarapharmacy on "ASCO - what's hot and what's not?"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/U2gCoe5gals/asco-whats-hot-and-whats-not</link>
<pubDate>Tue, 22 May 2012 15:32:38 +0000</pubDate>
<dc:creator>vadodarapharmacy</dc:creator>
<guid isPermaLink="false">4907@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;can nano technology bring drastic change in pharmacutic dosage form? how?
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/U2gCoe5gals" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/asco-whats-hot-and-whats-not#post-4907</feedburner:origLink></item>
<item>
<title>News on "FDA staff shoot down Pfizer rare disease drug"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/Ei7H8tabbMw/fda-staff-shoot-down-pfizer-rare-disease-drug</link>
<pubDate>Tue, 22 May 2012 14:45:29 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4906@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Treatment for familial amyloid polyneuropathy rejected by the US Food and Drug Administration in spite of approval in Europe, where tafamidis trades as Vyndaqel...&lt;/p&gt;
&lt;p&gt;More on the story at Reuters:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://uk.reuters.com/article/2012/05/22/business-us-fda-pfizer-idUKBRE84L0ON20120522" target="_blank"&gt;http://uk.reuters.co...dUKBRE84L0ON20120522&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/Ei7H8tabbMw" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/fda-staff-shoot-down-pfizer-rare-disease-drug#post-4906</feedburner:origLink></item>
<item>
<title>News on "New study shows Japan most expensive for investing in clinical trials"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/C_jxLPzEfT0/new-study-shows-japan-most-expensive-for-investing-in-clinical-trials</link>
<pubDate>Tue, 22 May 2012 14:35:26 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4905@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Australia second-most expensive in the survey of 14 countries...&lt;/p&gt;
&lt;p&gt;More on the story at The Pharma Letter:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.thepharmaletter.com/file/113474/new-study-shows-japan-most-expensive-for-investing-in-clinical-trials-followed-by-australia.html" target="_blank"&gt;http://www.thepharma...ed-by-australia.html&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/C_jxLPzEfT0" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/new-study-shows-japan-most-expensive-for-investing-in-clinical-trials#post-4905</feedburner:origLink></item>
<item>
<title>News on "How does pharma's CEO pay rank?"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/go6ZYhXBOq8/how-does-pharmas-ceo-pay-rank</link>
<pubDate>Tue, 22 May 2012 14:29:58 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4904@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Comparisons with pay in other industries...&lt;/p&gt;
&lt;p&gt;More information at FiercePharma:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.fiercepharma.com/story/how-does-pharmas-ceo-pay-rank/2012-05-21" target="_blank"&gt;http://www.fiercepha...-pay-rank/2012-05-21&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/go6ZYhXBOq8" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/how-does-pharmas-ceo-pay-rank#post-4904</feedburner:origLink></item>
<item>
<title>News on "FDA Reviewer Backs Expanded Approval Of Bayer, J&amp;J's Xarelto"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/9az9iJSA_38/fda-reviewer-backs-expanded-approval-of-bayer-jjs-xarelto</link>
<pubDate>Tue, 22 May 2012 10:02:17 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4903@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;New indication given positive opinion for Xarelto (rivaroxaban) in acute coronary syndrome...&lt;/p&gt;
&lt;p&gt;More on the story at Fox Business:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.foxbusiness.com/news/2012/05/21/fda-reviewer-backs-expanded-approval-bayer-jj-xarelto/" target="_blank"&gt;http://www.foxbusine...al-bayer-jj-xarelto/&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/9az9iJSA_38" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/fda-reviewer-backs-expanded-approval-of-bayer-jjs-xarelto#post-4903</feedburner:origLink></item>
<item>
<title>News on "Third of malaria drugs 'are fake'"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/Y_fQory1iAk/third-of-malaria-drugs-are-fake</link>
<pubDate>Tue, 22 May 2012 09:59:00 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4902@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Data come from samples of various antimalaria drugs used in several south-east Asian countries and 21 sub-Saharan African countries...&lt;/p&gt;
&lt;p&gt;More on the story at the BBC:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.bbc.co.uk/news/health-18147085" target="_blank"&gt;http://www.bbc.co.uk...news/health-18147085&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/Y_fQory1iAk" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/third-of-malaria-drugs-are-fake#post-4902</feedburner:origLink></item>
<item>
<title>News on "FDA’s $6.4 Billion Plan For Quick Reviews Moves To Senate"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/Qfu8yo5P4eE/fda%e2%80%99s-64-billion-plan-for-quick-reviews-moves-to-senate</link>
<pubDate>Mon, 21 May 2012 15:50:52 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4901@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Pharma firms may get faster approvals in return for fees paid to the US Food and Drug Administration...&lt;/p&gt;
&lt;p&gt;More on the story at Bloomberg:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.bloomberg.com/news/2012-05-21/fda-s-6-4-billion-plan-for-quick-reviews-moves-to-senate.html" target="_blank"&gt;http://www.bloomberg...moves-to-senate.html&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/Qfu8yo5P4eE" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/fda%e2%80%99s-64-billion-plan-for-quick-reviews-moves-to-senate#post-4901</feedburner:origLink></item>
<item>
<title>News on "Indian drug regulator 'colluded with pharma companies'"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/rC_j33Updo0/indian-drug-regulator-colluded-with-pharma-companies</link>
<pubDate>Mon, 21 May 2012 15:41:34 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4900@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Questions over clinical trials standards...&lt;/p&gt;
&lt;p&gt;More on the story at PMLiVE:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.pmlive.com/pharma_news/indian_drug_regulator_colluded_with_pharma_companies_404057" target="_blank"&gt;http://www.pmlive.co...rma_companies_404057&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/rC_j33Updo0" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/indian-drug-regulator-colluded-with-pharma-companies#post-4900</feedburner:origLink></item>
<item>
<title>News on "Pfizer Recalls 650,000 Bottles Of Advil Liqui-Gels"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/dipRv-06GxE/pfizer-recalls-650000-bottles-of-advil-liqui-gels</link>
<pubDate>Mon, 21 May 2012 09:57:44 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4898@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Pfizer initiated a recall of 650,000 units of Advil Liqui-Gels (for headache pain) due to a strong odour...&lt;/p&gt;
&lt;p&gt;More on the story at Bloomberg:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.bloomberg.com/news/2012-05-18/pfizer-recalls-650-000-bottles-of-advil-liqui-gels.html" target="_blank"&gt;http://www.bloomberg...dvil-liqui-gels.html&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/dipRv-06GxE" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/pfizer-recalls-650000-bottles-of-advil-liqui-gels#post-4898</feedburner:origLink></item>
<item>
<title>News on "AstraZeneca in experimental drugs push"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/OODLW5cjbnU/astrazeneca-in-experimental-drugs-push</link>
<pubDate>Mon, 21 May 2012 09:45:18 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4897@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Mix of various M&amp;amp;A and partnership and licensing deals being considered for 2012, according to reported comments of AZ's head of R&amp;amp;D...&lt;/p&gt;
&lt;p&gt;More on the story at the Financial Times:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.ft.com/cms/s/0/b57f5f58-a111-11e1-aac1-00144feabdc0.html#axzz1vUYRjdjk" target="_blank"&gt;http://www.ft.com/cm...0.html#axzz1vUYRjdjk&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/OODLW5cjbnU" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/astrazeneca-in-experimental-drugs-push#post-4897</feedburner:origLink></item>
<item>
<title>News on "Osiris GvHD therapy is world's first approved stem cell drug"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/Oop_FFktCTA/osiris-gvhd-therapy-is-worlds-first-approved-stem-cell-drug</link>
<pubDate>Mon, 21 May 2012 09:40:36 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4896@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Prochymal (remestemcel-L) is a drug with a stem cell as its active ingredient - the world's first to reach market having been given the green light by the Canadian regulatory authority for use in acute GvHD (graft versus host disease) resulting from bone marrow transplantation...&lt;/p&gt;
&lt;p&gt;More on the story at Pharma Times:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.pharmatimes.com/Article/12-05-21/Osiris_GvHD_therapy_is_world_s_first_approved_stem_cell_drug.aspx" target="_blank"&gt;http://www.pharmatim..._stem_cell_drug.aspx&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/Oop_FFktCTA" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/osiris-gvhd-therapy-is-worlds-first-approved-stem-cell-drug#post-4896</feedburner:origLink></item>
<item>
<title>News on "Statins 'prevent cancer' in transplant patients"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/UjwqQ0cT2dA/statins-prevent-cancer-in-transplant-patients</link>
<pubDate>Mon, 21 May 2012 09:29:20 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4895@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;A study of 255 post-op patients shows that routine use of statins following surgery for a new heart appears to protect against cancer... &lt;/p&gt;
&lt;p&gt;More on the story at The Telegraph:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.telegraph.co.uk/health/healthnews/9275480/Statins-prevent-cancer-in-transplant-patients.html" target="_blank"&gt;http://www.telegraph...splant-patients.html&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/UjwqQ0cT2dA" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/statins-prevent-cancer-in-transplant-patients#post-4895</feedburner:origLink></item>
<item>
<title>News on "Those Johnson &amp; Johnson Recalls Keep On Coming"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/wjlm5GtCJeQ/those-johnson-johnson-recalls-keep-on-coming</link>
<pubDate>Fri, 18 May 2012 14:55:24 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4894@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;One lot of the over-the-counter diarrhoea preparation Immodium is the latest in a series of recalls at J&amp;amp;J...&lt;/p&gt;
&lt;p&gt;More on the story at Pharmalot:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.pharmalot.com/2012/05/those-johnson-johnson-recalls-keep-on-coming/" target="_blank"&gt;http://www.pharmalot...alls-keep-on-coming/&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/wjlm5GtCJeQ" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/those-johnson-johnson-recalls-keep-on-coming#post-4894</feedburner:origLink></item>
<item>
<title>News on "US FDA reviews new drugs faster than EMA, Health Canada, says study"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/zGrdB0CJGRo/us-fda-reviews-new-drugs-faster-than-ema-health-canada-says-study</link>
<pubDate>Fri, 18 May 2012 14:43:41 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4893@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Study says European Medicines Agency lags behind the US regulator on speed of approval for new pharmaceutical products...&lt;/p&gt;
&lt;p&gt;More on the story at Pharma Times:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.pharmatimes.com/Article/12-05-18/US_FDA_reviews_new_drugs_faster_than_EMA_Health_Canada_says_study.aspx" target="_blank"&gt;http://www.pharmatim...nada_says_study.aspx&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/zGrdB0CJGRo" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/us-fda-reviews-new-drugs-faster-than-ema-health-canada-says-study#post-4893</feedburner:origLink></item>
<item>
<title>News on "CHMP meeting: Servier's Protelos backed, review on Novartis' Gilenya not finished"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/CurQutQOhuA/chmp-meeting-serviers-protelos-backed-review-on-novartis-gilenya-not-finished-1</link>
<pubDate>Fri, 18 May 2012 09:23:22 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4892@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;News from the monthly review meeting at the European Medicines Agency...&lt;/p&gt;
&lt;p&gt;More on the story at Pharma Times:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.pharmatimes.com/article/12-03-19/CHMP_meeting_Servier_s_Protelos_backed_review_on_Novartis_Gilenya_not_finished.aspx" target="_blank"&gt;http://www.pharmatim...ya_not_finished.aspx&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/CurQutQOhuA" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/chmp-meeting-serviers-protelos-backed-review-on-novartis-gilenya-not-finished-1#post-4892</feedburner:origLink></item>
<item>
<title>News on "FDA OKs multiple companies to sell generic Plavix"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/AM08SbAPJSE/fda-oks-multiple-companies-to-sell-generic-plavix</link>
<pubDate>Fri, 18 May 2012 09:07:16 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4891@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Seven different pharma firms now have US Food and Drug Administration approval to sell the anticoagulant clopidogrel, which has just come off patent as Plavix, a brand marketed by Bristol-Myers Squibb and Sanofi...&lt;/p&gt;
&lt;p&gt;More on the story from the Associated Press at Google News:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.google.com/hostednews/ap/article/ALeqM5hU7ye0ksBt7XqDIuaGtcWU3-_OAQ?docId=4f36a320cfeb4c52bb5c36c15fb3df55" target="_blank"&gt;http://www.google.co...4c52bb5c36c15fb3df55&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;"Another one bites the dust: Plavix falls off patent today:"&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.pharmaphorum.com/forums/topic/another-one-bites-the-dust-plavix-falls-off-patent-today" target="_blank"&gt;http://www.pharmapho...lls-off-patent-today&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/AM08SbAPJSE" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/fda-oks-multiple-companies-to-sell-generic-plavix#post-4891</feedburner:origLink></item>
<item>
<title>News on "Human Genome Sciences devises poison pill to ward off GSK bid"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/Hk3ZanLNFJo/human-genome-sciences-devises-poison-pill-to-ward-off-gsk-bid</link>
<pubDate>Thu, 17 May 2012 16:13:15 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4890@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Share moves being considered as a means to rebuff GlaxoSmithKline's hostile advances...&lt;/p&gt;
&lt;p&gt;More on the story at proactiveinvestors:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.proactiveinvestors.co.uk/companies/news/42965/human-genome-sciences-devises-poison-pill-to-ward-off-gsk-bid-42965.html" target="_blank"&gt;http://www.proactive...f-gsk-bid-42965.html&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/Hk3ZanLNFJo" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/human-genome-sciences-devises-poison-pill-to-ward-off-gsk-bid#post-4890</feedburner:origLink></item>
<item>
<title>News on "ASCO data to shine new light on Pfizer, Roche, J&amp;J drugs"</title>
<link>http://feedproxy.google.com/~r/pharmaphorum-forums/~3/_GkA0_jwIpA/asco-data-to-shine-new-light-on-pfizer-roche-jj-drugs</link>
<pubDate>Thu, 17 May 2012 16:08:37 +0000</pubDate>
<dc:creator>News</dc:creator>
<guid isPermaLink="false">4889@http://www.pharmaphorum.com/forums/</guid>
<description>&lt;p&gt;Talk of cancer's major players lining up for the spotlight at the up-coming ASCO conference...&lt;/p&gt;
&lt;p&gt;More on the story at FiercePharma:&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.fiercepharma.com/story/asco-data-shine-new-light-pfizer-roche-jj-drugs/2012-05-16" target="_blank"&gt;http://www.fiercepha...-jj-drugs/2012-05-16&lt;/a&gt;
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/pharmaphorum-forums/~4/_GkA0_jwIpA" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.pharmaphorum.com/forums/topic/asco-data-to-shine-new-light-on-pfizer-roche-jj-drugs#post-4889</feedburner:origLink></item>

</channel>
</rss>

